These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30647802)

  • 1. Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis.
    Nagai M; Imai Y; Wada Y; Kusakabe M; Yamanishi K
    Dis Markers; 2018; 2018():9758473. PubMed ID: 30647802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
    Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
    Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presepsin: A potential superior diagnostic biomarker for the postmortem differentiation of sepsis based on the Sepsis-3 criteria.
    Unuma K; Makino Y; Sasaki Y; Iwase H; Uemura K
    Forensic Sci Int; 2019 Jun; 299():17-20. PubMed ID: 30954003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
    Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
    Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
    Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
    Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sepsis biomarkers dynamics as an indicator of intensive care effectiveness].
    Zvyagin AA; Demidova VS; Smirnov GV
    Khirurgiia (Mosk); 2019; (2):53-57. PubMed ID: 30855591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presepsin values as markers of severity of sepsis.
    Aliu-Bejta A; Atelj A; Kurshumliu M; Dreshaj S; Baršić B
    Int J Infect Dis; 2020 Jun; 95():1-7. PubMed ID: 32251795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of elevated procalcitonin and presepsin levels after severe trauma: a pilot cohort study.
    Hoshino K; Irie Y; Mizunuma M; Kawano K; Kitamura T; Ishikura H
    Anaesth Intensive Care; 2017 Sep; 45(5):600-604. PubMed ID: 28911289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
    de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
    Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study of Changes in Presepsin Concentrations Compared With Changes in Procalcitonin and C-Reactive Protein Concentrations After Cardiovascular Surgery.
    Saito J; Hashiba E; Mikami A; Kudo T; Niwa H; Hirota K
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1262-1267. PubMed ID: 28431809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis.
    Tambo M; Taguchi S; Nakamura Y; Okegawa T; Fukuhara H
    BMC Urol; 2020 Mar; 20(1):23. PubMed ID: 32160878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
    Yoon SH; Kim EH; Kim HY; Ahn JG
    BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Use of Presepsin Compared with That of Procalcitonin in Children with Sepsis].
    Nakanishi K; Kasashima S; Ishii Y; Shimoeda H; Kawashima A
    Rinsho Byori; 2016 Oct; 64(10):1128-1133. PubMed ID: 30609469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
    Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
    Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
    Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
    J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentration of Soluble CD14-Subtype (Presepsin) in Plasma of Non-Inflammatory and Septic Febrile Children].
    Yamaguchi H; Takuma A; Fukuoka E; Oto H; Inoue M; Nagahama T; Fukuoka S; Soga T; Umeda Y; Kimura S
    Rinsho Byori; 2016 Sep; 64(9):1001-1006. PubMed ID: 30609451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis.
    Kumar N; Dayal R; Singh P; Pathak S; Pooniya V; Goyal A; Kamal R; Mohanty KK
    Indian J Pediatr; 2019 Feb; 86(2):177-179. PubMed ID: 29577181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presepsin for the detection of early-onset sepsis in preterm newborns.
    Montaldo P; Rosso R; Santantonio A; Chello G; Giliberti P
    Pediatr Res; 2017 Feb; 81(2):329-334. PubMed ID: 27925621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of sepsis biomarkers may indicate an invasive fungal infection in haematological patients.
    Stoma I; Karpov I; Uss A; Krivenko S; Iskrov I; Milanovich N; Vlasenkova S; Lendina I; Belyavskaya K; Cherniak V
    Biomarkers; 2019 Jun; 24(4):401-406. PubMed ID: 30907674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.